\-\ Texto\\:\\ \ \(0\)\
\-\ dermoid\\ cysts\\ rarely\\ undergo\\ malignant\\ degeneration\\ \\(0\\.17\\-2\\%\\)\\,\\ however\\ complete\\ surgical\\ removal\\ via\\ laparotomy\\ or\\ laparoscopy\\ is\\ the\\ treatment\\ of\\ choice\\ secondary\\ to\\ the\\ risk\\ of\\ torsion\\ and\\/or\\ rupture\\.\\ \\ histopathologic\\ evaluation\\ of\\ the\\ specimen\\ should\\ follow\\ removal\\;\\ if\\ immature\\ elements\\ are\\ found\\ in\\ the\\ specimen\\,\\ then\\ standard\\ staging\\ should\\ be\\ performed\\.\ \(0\)\
\-\ pelvic\\ ultrasound\\ \\â\\€\\“\\ 2\\.6\\ x\\ 2\\.3\\ x\\ 2\\.3\\ cm\\ hyperechoic\\ right\\ ovarian\\ lesion\\.\ \(0\)\
\-\ ct\\,\\ abdomen\\/pelvis\\ w\\/\\ iv\\ contrast\\ \\â\\€\\“\\ 2\\.1\\ x\\ 2\\.5\\ cm\\ mass\\ in\\ right\\ ovary\\ containing\\ fat\\ attenuation\\,\\ most\\ consistent\\ with\\ a\\ dermoid\\ cyst\\.\ \(0\)\
\-\ ovarian\\ dermoid\\ cyst\ \(1\)\
\-\ dermoid\\ cyst\\ \\(benign\\ cystic\\ teratoma\\)\ \(1\)\
\-\ hemorrhagic\\ cyst\ \(15\)\
\-\ mucinous\\ cystadenoma\ \(9\)\
\-\ endometrioma\ \(17\)\
\-\ ovarian\\ carcinoma\ \(6\)\
\-\ 40\\ yo\\ ad\\ female\\ with\\ an\\ asymptomatic\\ right\\ ovarian\\ mass\\ identified\\ during\\ a\\ pelvic\\ ultrasound\\ for\\ uterine\\ fibroids\\.\ \(0\)\
\-\ dermoid\\ cysts\\,\\ also\\ called\\ benign\\ cystic\\ teratomas\\,\\ are\\ the\\ most\\ common\\ benign\\ ovarian\\ tumors\\.\\ \\ these\\ cysts\\ are\\ neoplastic\\ tumors\\ derived\\ from\\ germ\\ cells\\ and\\ contain\\ differentiated\\ tissue\\ from\\ the\\ three\\ germ\\ cell\\ layers\\:\\ ectoderm\\,\\ mesoderm\\ and\\ endoderm\\.\\ \\ most\\ commonly\\ found\\ are\\ endodermal\\ elements\\ such\\ as\\ skin\\,\\ sweat\\ and\\ sebaceous\\ glands\\,\\ hair\\,\\ and\\ sebum\\.\\ \\ teeth\\,\\ bone\\,\\ fat\\,\\ and\\ endocrine\\ tissue\\ may\\ also\\ be\\ found\\ in\\ these\\ cysts\\.\ \(0\)\
\-\ dermoid\\ cysts\\ are\\ oftentimes\\ identified\\ incidentally\\ on\\ routine\\ pelvic\\ exam\\.\\ \\ cysts\\ are\\ usually\\ asymptomatic\\,\\ unilateral\\,\\ nontender\\,\\ and\\ mobile\\.\\ \\ pelvic\\ ultrasound\\ is\\ the\\ initial\\ modality\\ used\\ to\\ evaluate\\ the\\ mass\\.\\ \\ imaging\\ most\\ commonly\\ reveals\\ a\\ complex\\,\\ predominantly\\ solid\\ mass\\ with\\ echogenic\\ internal\\ components\\ \\(i\\.e\\.\\ bone\\,\\ fat\\)\\,\\ but\\ may\\ also\\ vary\\ from\\ completely\\ cystic\\ to\\ completely\\ solid\\ depending\\ on\\ the\\ contents\\ of\\ the\\ cyst\\.\\ \\ cysts\\ containing\\ large\\ amounts\\ of\\ fat\\ are\\ associated\\ with\\ hypoechoic\\ distal\\ shadowing\\ as\\ was\\ seen\\ in\\ this\\ patient\\.\\ \\ pelvic\\ computed\\ tomography\\ is\\ a\\ helpful\\ adjunct\\ to\\ assist\\ in\\ identifying\\ the\\ cyst\\ contents\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cysts\\:\\ 0\\.07254553554123705\ \(0\)\
\-\ dermoid\\:\\ 0\\.07236292566201312\ \(0\)\
\-\ ovarian\\:\\ 0\\.06053008739207537\ \(0\)\
\-\ pelvic\\:\\ 0\\.05429180691277544\ \(0\)\
\-\ cyst\\:\\ 0\\.04265704896642915\ \(0\)\
\-\ 2\\.3\\:\\ 0\\.03824434114149375\ \(0\)\
\-\ fat\\:\\ 0\\.032184672729184315\ \(0\)\
\-\ specimen\\:\\ 0\\.03174389455017066\ \(0\)\
\-\ contents\\:\\ 0\\.029885661779580335\ \(0\)\
\-\ elements\\:\\ 0\\.029030241727067536\ \(0\)\
\-\ benign\\:\\ 0\\.027390560684518898\ \(0\)\
\-\ germ\\:\\ 0\\.027375041915133496\ \(0\)\
\-\ 0\\.17\\-2\\:\\ 0\\.027292626699586684\ \(0\)\
\-\ containing\\:\\ 0\\.02686180563150645\ \(0\)\
\-\ x\\:\\ 0\\.026183278656478116\ \(0\)\
\-\ completely\\:\\ 0\\.02542407568206913\ \(0\)\
\-\ are\\:\\ 0\\.025244944605904682\ \(0\)\
\-\ sebum\\:\\ 0\\.02514666019630512\ \(0\)\
\-\ oftentimes\\:\\ 0\\.02514666019630512\ \(0\)\
\-\ found\\:\\ 0\\.02501262180605677\ \(0\)\
\-\ most\\:\\ 0\\.024431394944000942\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.023812415630900915\ \(0\)\
\-\ ultrasound\\:\\ 0\\.023546030201296933\ \(0\)\
\-\ endodermal\\:\\ 0\\.023000693693023554\ \(0\)\
\-\ cystic\\:\\ 0\\.022891325454350697\ \(0\)\
\-\ endoderm\\:\\ 0\\.022309846784930025\ \(0\)\
\-\ laparoscopy\\:\\ 0\\.021745383760800135\ \(0\)\
\-\ ectoderm\\:\\ 0\\.021745383760800135\ \(0\)\
\-\ mesoderm\\:\\ 0\\.02126813707402844\ \(0\)\
\-\ solid\\:\\ 0\\.0211043136378104\ \(0\)\
\-\ removal\\:\\ 0\\.020859325401239557\ \(0\)\
\-\ histopathologic\\:\\ 0\\.02016388028164846\ \(0\)\
\-\ commonly\\:\\ 0\\.019966138968765583\ \(0\)\
\-\ tumors\\:\\ 0\\.019874404691458212\ \(0\)\
\-\ sweat\\:\\ 0\\.019351607017043224\ \(0\)\
\-\ adjunct\\:\\ 0\\.019351607017043224\ \(0\)\
\-\ derived\\:\\ 0\\.019122170570746874\ \(0\)\
\-\ sebaceous\\:\\ 0\\.01890857034942504\ \(0\)\
\-\ identified\\:\\ 0\\.018906916663692392\ \(0\)\
\-\ amounts\\:\\ 0\\.018521068358855364\ \(0\)\
\-\ teratomas\\:\\ 0\\.018344107325295154\ \(0\)\
\-\ assist\\:\\ 0\\.0181767165473686\ \(0\)\
\-\ ad\\:\\ 0\\.018017913778366895\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.01788602104022345\ \(0\)\
\-\ immature\\:\\ 0\\.01786686063852345\ \(0\)\
\-\ 2\\.1\\:\\ 0\\.01786686063852345\ \(0\)\
\-\ 2\\.6\\:\\ 0\\.017453450754237005\ \(0\)\
\-\ abdomen\\/pelvis\\:\\ 0\\.017453450754237005\ \(0\)\
\-\ hair\\:\\ 0\\.01720564051376166\ \(0\)\
\-\ laparotomy\\:\\ 0\\.01708879739307173\ \(0\)\
\-\ fibroids\\:\\ 0\\.01697620406746531\ \(0\)\
\-\ should\\:\\ 0\\.01686816434606068\ \(0\)\
\-\ vary\\:\\ 0\\.01686756221046447\ \(0\)\
\-\ teeth\\:\\ 0\\.016661087366815333\ \(0\)\
\-\ identifying\\:\\ 0\\.01656279418317886\ \(0\)\
\-\ layers\\:\\ 0\\.016467525890092934\ \(0\)\
\-\ endocrine\\:\\ 0\\.0163751018555738\ \(0\)\
\-\ endometrioma\\:\\ 0\\.01628535715937178\ \(0\)\
\-\ \\,\\:\\ 0\\.015924121501016904\ \(0\)\
\-\ mucinous\\:\\ 0\\.01587194727508533\ \(0\)\
\-\ glands\\:\\ 0\\.015720894135241886\ \(0\)\
\-\ also\\:\\ 0\\.015646621613035462\ \(0\)\
\-\ cystadenoma\\:\\ 0\\.015372665084385263\ \(0\)\
\-\ staging\\:\\ 0\\.01524364744847019\ \(0\)\
\-\ mobile\\:\\ 0\\.015059674010480095\ \(0\)\
\-\ torsion\\:\\ 0\\.014775440111863616\ \(0\)\
\-\ mass\\:\\ 0\\.014717783367771698\ \(0\)\
\-\ contain\\:\\ 0\\.014616637342861914\ \(0\)\
\-\ modality\\:\\ 0\\.014515120863533768\ \(0\)\
\-\ 2\\.5\\:\\ 0\\.01432155938681137\ \(0\)\
\-\ ovary\\:\\ 0\\.014275002490945923\ \(0\)\
\-\ cm\\:\\ 0\\.014191678748092792\ \(0\)\
\-\ differentiated\\:\\ 0\\.014139390656090215\ \(0\)\
\-\ i\\.e\\:\\ 0\\.014139390656090215\ \(0\)\
\-\ tomography\\:\\ 0\\.014139390656090215\ \(0\)\
\-\ shadowing\\:\\ 0\\.014052174318732022\ \(0\)\
\-\ computed\\:\\ 0\\.013967347773257983\ \(0\)\
\-\ called\\:\\ 0\\.013884783540805473\ \(0\)\
\-\ these\\:\\ 0\\.013769936173113562\ \(0\)\
\-\ depending\\:\\ 0\\.01376492436996742\ \(0\)\
\-\ w\\/\\:\\ 0\\.013725980771803765\ \(0\)\
\-\ choice\\:\\ 0\\.013687520957566748\ \(0\)\
\-\ helpful\\:\\ 0\\.013687520957566748\ \(0\)\
\-\ uterine\\:\\ 0\\.013574927631960323\ \(0\)\
\-\ nontender\\:\\ 0\\.013574927631960323\ \(0\)\
\-\ standard\\:\\ 0\\.013538288444198706\ \(0\)\
\-\ neoplastic\\:\\ 0\\.013538288444198706\ \(0\)\
\-\ undergo\\:\\ 0\\.013430902815753225\ \(0\)\
\-\ degeneration\\:\\ 0\\.013430902815753225\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.013226698581103698\ \(0\)\
\-\ echogenic\\:\\ 0\\.013161517747673877\ \(0\)\
\-\ bone\\:\\ 0\\.01314820236198062\ \(0\)\
\-\ unilateral\\:\\ 0\\.013129434815675281\ \(0\)\
\-\ components\\:\\ 0\\.012973825420068814\ \(0\)\
\-\ rarely\\:\\ 0\\.012684271060902178\ \(0\)\
\-\ tissue\\:\\ 0\\.012541307668437113\ \(0\)\
\-\ predominantly\\:\\ 0\\.012394223122582293\ \(0\)\
\-\ teratoma\\:\\ 0\\.012369154360252203\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.01234428695561671\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.012060487610335522\ \(0\)\
\-\ incidentally\\:\\ 0\\.01199342415280865\ \(0\)\
\-\ from\\:\\ 0\\.011762560803289898\ \(0\)\
\-\ may\\:\\ 0\\.01160574841422987\ \(0\)\
\-\ via\\:\\ 0\\.011356111291495496\ \(0\)\
\-\ rupture\\:\\ 0\\.011232608724847501\ \(0\)\
\-\ and\\/or\\:\\ 0\\.011181150888203414\ \(0\)\
\-\ 40\\:\\ 0\\.011130534361882891\ \(0\)\
\-\ evaluate\\:\\ 0\\.010694198941972363\ \(0\)\
\-\ attenuation\\:\\ 0\\.010636597741257086\ \(0\)\
\-\ cells\\:\\ 0\\.010608194099535596\ \(0\)\
\-\ routine\\:\\ 0\\.010608194099535596\ \(0\)\
\-\ complex\\:\\ 0\\.010594089404378133\ \(0\)\
\-\ reveals\\:\\ 0\\.010350612230015552\ \(0\)\
\-\ skin\\:\\ 0\\.010161389892380737\ \(0\)\
\-\ used\\:\\ 0\\.010149176956495238\ \(0\)\
\-\ iv\\:\\ 0\\.009654566369848587\ \(0\)\
\-\ risk\\:\\ 0\\.009582683118758782\ \(0\)\
\-\ malignant\\:\\ 0\\.009562447914487\ \(0\)\
\-\ then\\:\\ 0\\.00941475813752969\ \(0\)\
\-\ complete\\:\\ 0\\.009310761405529581\ \(0\)\
\-\ three\\:\\ 0\\.00891834126423192\ \(0\)\
\-\ internal\\:\\ 0\\.008869584741110747\ \(0\)\
\-\ initial\\:\\ 0\\.00876650818352727\ \(0\)\
\-\ follow\\:\\ 0\\.008406190315623636\ \(0\)\
\-\ right\\:\\ 0\\.00837428831991099\ \(0\)\
\-\ such\\:\\ 0\\.008270380154306044\ \(0\)\
\-\ be\\:\\ 0\\.00815948435507077\ \(0\)\
\-\ during\\:\\ 0\\.008096003869733153\ \(0\)\
\-\ usually\\:\\ 0\\.00803383360330266\ \(0\)\
\-\ as\\:\\ 0\\.008003575887889337\ \(0\)\
\-\ yo\\:\\ 0\\.007960840629420316\ \(0\)\
\-\ evaluation\\:\\ 0\\.007684949832281139\ \(0\)\
\-\ carcinoma\\:\\ 0\\.007498228080544479\ \(0\)\
\-\ secondary\\:\\ 0\\.007396377605290426\ \(0\)\
\-\ performed\\:\\ 0\\.007376403502251762\ \(0\)\
\-\ however\\:\\ 0\\.007366464568411983\ \(0\)\
\-\ distal\\:\\ 0\\.007192812968873148\ \(0\)\
\-\ if\\:\\ 0\\.007178772240806921\ \(0\)\
\-\ cell\\:\\ 0\\.007146256073007698\ \(0\)\
\-\ common\\:\\ 0\\.006923427900793799\ \(0\)\
\-\ \\(\\:\\ 0\\.006709242039416661\ \(0\)\
\-\ \\)\\:\\ 0\\.006627285066067849\ \(0\)\
\-\ in\\:\\ 0\\.006523176937155649\ \(0\)\
\-\ consistent\\:\\ 0\\.006486991544369051\ \(0\)\
\-\ \\;\\:\\ 0\\.006270653834218556\ \(0\)\
\-\ associated\\:\\ 0\\.006242918148321059\ \(0\)\
\-\ imaging\\:\\ 0\\.006198370973546758\ \(0\)\
\-\ \\%\\:\\ 0\\.006171272549058847\ \(0\)\
\-\ contrast\\:\\ 0\\.005921906151108066\ \(0\)\
\-\ exam\\:\\ 0\\.005811869783125505\ \(0\)\
\-\ large\\:\\ 0\\.005784961089260309\ \(0\)\
\-\ but\\:\\ 0\\.005642425080599188\ \(0\)\
\-\ surgical\\:\\ 0\\.005561058112233602\ \(0\)\
\-\ female\\:\\ 0\\.005438886289312179\ \(0\)\
\-\ lesion\\:\\ 0\\.005388715869970448\ \(0\)\
\-\ treatment\\:\\ 0\\.005354851268114202\ \(0\)\
\-\ to\\:\\ 0\\.005288769144804784\ \(0\)\
\-\ seen\\:\\ 0\\.005227949272655388\ \(0\)\
\-\ is\\:\\ 0\\.005222514969517576\ \(0\)\
\-\ a\\:\\ 0\\.004911452654100325\ \(0\)\
\-\ the\\:\\ 0\\.0047081799744268845\ \(0\)\
\-\ on\\:\\ 0\\.004482297290188409\ \(0\)\
\-\ ct\\:\\ 0\\.0037006305058577185\ \(0\)\
\-\ an\\:\\ 0\\.0036584051525843033\ \(0\)\
\-\ \\:\\:\\ 0\\.003499302835884412\ \(0\)\
\-\ and\\:\\ 0\\.0033438205399173703\ \(0\)\
\-\ or\\:\\ 0\\.0031006896252746365\ \(0\)\
\-\ was\\:\\ 0\\.003059682731311724\ \(0\)\
\-\ this\\:\\ 0\\.0029756570071644986\ \(0\)\
\-\ patient\\:\\ 0\\.0026519874022179197\ \(0\)\
\-\ for\\:\\ 0\\.0022573007697916877\ \(0\)\
\-\ of\\:\\ 0\\.0018034644086375917\ \(0\)\
\-\ \\.\\:\\ 0\\.0017584909521905277\ \(0\)\
\-\ with\\:\\ 0\\.001448968124952195\ \(0\)\
